Fidelity MSCI Health Care Index ETF (FHLC)
| Assets | $2.60B |
| Expense Ratio | 0.08% |
| PE Ratio | 30.09 |
| Shares Out | 40.10M |
| Dividend (ttm) | $0.99 |
| Dividend Yield | 1.49% |
| Ex-Dividend Date | Dec 20, 2024 |
| Payout Ratio | 44.57% |
| 1-Year Return | +3.34% |
| Volume | 83,208 |
| Open | 65.95 |
| Previous Close | 66.06 |
| Day's Range | 65.72 - 66.28 |
| 52-Week Low | 63.99 |
| 52-Week High | 74.48 |
| Beta | 0.70 |
| Holdings | 368 |
| Inception Date | Oct 21, 2013 |
About FHLC
Fund Home PageThe Fidelity MSCI Health Care Index ETF (FHLC) is an exchange-traded fund that is based on the MSCI US IMI 25/50 Health Care index, a market-cap-weighted index of stocks in the broad US health care sector. FHLC was launched on Oct 21, 2013 and is issued by Fidelity.
Top 10 Holdings
48.84% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 10.55% |
| UnitedHealth Group Incorporated | UNH | 7.85% |
| Johnson & Johnson | JNJ | 5.92% |
| AbbVie Inc. | ABBV | 5.27% |
| Merck & Co., Inc. | MRK | 4.23% |
| Thermo Fisher Scientific Inc. | TMO | 3.40% |
| Abbott Laboratories | ABT | 3.38% |
| Intuitive Surgical, Inc. | ISRG | 3.17% |
| Pfizer Inc. | PFE | 2.54% |
| Danaher Corporation | DHR | 2.53% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 20, 2024 | $0.258 | n/a |
| Sep 20, 2024 | $0.250 | Sep 24, 2024 |
| Jun 21, 2024 | $0.242 | Jun 25, 2024 |
| Mar 15, 2024 | $0.238 | Mar 20, 2024 |
| Dec 15, 2023 | $0.224 | Dec 20, 2023 |
| Sep 15, 2023 | $0.219 | Sep 20, 2023 |
News
Fidelity Crosses $100 Billion ETF Milestone
In mid-November, Fidelity Investments joined the select ‘$100 billion in ETF assets' club. While the firm still has a sizable presence in the mutual fund world, Fidelity's ETFs have been gaining tract...
FHLC ETF: Play Defensive For 2 Reasons
The Fidelity MSCI Healthcare Index ETF offers diversified exposure to healthcare, with a lower expense ratio and better performance than the Healthcare Select Sector SPDR Fund ETF. Economic uncertaint...
FHLC: Healthcare Dashboard For July
Monthly article series reports aggregate industry metrics in healthcare. Healthcare providers and life science tools are moderately overvalued, while pharmaceuticals and biotechnology have the worst v...
FHLC: Healthcare Dashboard For April
The healthcare sector is overvalued by 14% based on 11-year averages. Healthcare providers are not far from their valuation baseline, while the most overvalued subsector is healthcare equipment. Fast ...
Healthcare In 2024: Navigating The Biopharma Bull Run
The healthcare sector presents a unique investment opportunity in 2024 due to attractive valuation and uncorrelated/robust cashflow of healthcare. Biopharma companies have pricing power and ability to...
FHLC: Healthcare Can Work Well In 2024
Technology continues to outperform, but defensive sectors like Utilities, Consumer Staples, and Healthcare may see increased interest. The Fidelity MSCI Health Care Index ETF offers broad exposure to ...
FHLC Is Vulnerable In An Economic Downturn Due To Its Rich Valuation And Portfolio Mix
Fidelity MSCI Health Care Index ETF owns a portfolio of 400 US healthcare stocks and should benefit from long-term growth in the sector. FHLC has performed comparably to the S&P 500 in the long run. F...
FHLC: Long-Term Growth And Stability Make Healthcare A Low-Volatility Bet
The healthcare industry's potential for long-term growth and stability could give FHLC a silver lining as the market trajectory remains somewhat uncertain. Despite underperforming during bull markets,...
FHLC: A Stable Portfolio Of Healthcare Stocks Delivering Strong Returns
FHLC possesses a large-cap, stable portfolio of diversified healthcare stocks, which enjoys a low expense ratio and strong price growth over the long run. Over the long-run, FHLC's delivered double-di...
FHLC: Aging U.S. Demographics Should Boost This Health Care ETF
Healthcare is considered a defensive sector that should outperform during times of high inflation, weak economic growth, and challenging markets. In addition, demographics should be a tailwind as the ...
FHLC: Because A Healthy Investor Holds Health Care Stocks
The health care sector - as measured by the Fidelity Health Care ETF - outperformed the S&P 500 by ~12.2% over the past year. That's because health care is considered to be a relatively defensive sect...
ETF strategies helped pivot investors ‘away from consumer discretionary tech': Expert
Pacer ETFs President Sean O'Hara joins Yahoo Finance Live anchors Seana Smith and Dave Briggs to weigh in on the state of the ETF market and shares his thoughts on the Fed's approach to tamp down infl...
FHLC: Health Care Stocks Are Probably Fairly Valued
FHLC invests in health care stocks. Health care stocks are probably now fairly valued, although they remain cyclically well positioned.
Will FHLC Keep Your Portfolio Fit?
Health Care is one of the "defensive" sectors that is generally thought to weather times of inflation/recession better than most. That's because many health care issues must be timely dealt with regar...
FHLC: A Stable Healthcare ETF Composed Of Defensive Large-Cap Stocks
Healthcare ETFs like FHLC that comprise defensive stocks performed much better than other healthcare ETFs during the past three months. However, after recording 100% price growth between March 2020 an...
FHLC: Well Diversified, Strong Price Growth, Good Future Prospect
FHLC is a well-diversified healthcare ETF concentrated on large caps.
Fidelity MSCI Health Care Index Is An Interesting Healthcare Play With High Quality Equity Investments
Fidelity MSCI Health Care Index is a healthcare sector-focused fund investing in equity.
FHLC: Healthcare Could Outperform SPY
FHLC: Healthcare Could Outperform SPY
Biotech Innovations Remain At Forefront
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r...
Healthcare: A Wide Choice Of Large And Well-Established Companies
The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets...
Fidelity MSCI Health Care Index ETF: A Lot Going For It
FHLC's expense ratio is best-in-class, and the dividend growth profile has been quite commendable. Prospects of FHLC's top-10 look attractive, but valuations are exorbitant.
Health-care ETFs win the week as Biden presidency affirms Obamacare
Health-care exchange-traded funds ticked down fractionally in Friday morning trading, but were still on track to be the top performing sector for the week.
